How will the Contraceptives Market thrive through the market plunge?



Contraceptives Market report from DelveInsight provides an in-depth analysis of Contraceptives, as well as historical and forecasted market trends in the global market (North-America, Europe, Asia Pacific and Rest of the world).

Contraceptives Overview:

Contraceptives are products that help form either physical or chemical barriers against the fusion of gametes or prevent the implantation of the fertilized egg from taking place.

To Know in detail about the Contraceptives market outlook, treatment scenario and market trends, Click here; Contraceptives Market Insights 

What are the Key Highlights from the Contraceptives Market Report?

The Contraceptives market size was valued at USD 24.17 Billion in the year 2021 and is expected to grow at a CAGR of 5.19% during the forecasted period (2022-2027). In October 2021, Bayer and the US biotech company Daré Bioscience collaborated to develop a hormone-free monthly contraceptive. The device is a ring that is inserted into the vagina, providing contraception over three weeks without any action required by the user around the time of intercourse. In April 2021, the FDA approved Nextstellis by Mayne Pharma, a combination of drospirenone and estetrol tablets to prevent pregnancy. The first combination pill contains naturally occurring estrogen.

Contraceptives Market Drivers are - The increasing prevalence of breast cancer globally, Rising incidence of cardiovascular diseases, Rising prevalence of geriatric population, and Favorable Reimbursement Coverage. Contraceptives Market Barriers: high cost of Contraceptives systems, complications related to surgical procedures such as data security & privacy issues.

The market report on Contraceptives includes an overview of the industry as well as a PEST Analysis. The report also examines market drivers, market constraints, and unmet medical needs in order to identify the greatest prospects and analyze the market's underlying potential. 

Contraceptives Market Insights: 

The dynamics of the Contraceptives market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2022-2032. 

The Contraceptives market has been occupied by some leading companies in the manufacturing of the Contraceptives depending on the geography and the product type. 

The Contraceptives market is broad, with a large variety of products accessible, and Contraceptives key companies such as Teva Pharmaceutical Industries Ltd, TherapeuticsMD, Inc., AbbVie Inc., Bayer AG, The Cooper Companies Inc., FemCap Inc, Veru Inc., Meril Life Sciences Pvt. Ltd., Pregna International Limited., Reckitt Benckiser Group PLC., Viatris Inc., EUROGINE, S.L, Gedeon Richter Plc., Agile Therapeutics., Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Shanghai Dahua Pharmaceutical Co., Ltd., Pfizer Inc., Contech Devices Private Limited, Cupid Limited, are present. 

What are the key benefits of the Contraceptives market report?


  1. Contraceptives market report covers a descriptive overview and comprehensive insight of the Contraceptives market trends and Contraceptives market globally.

  2. Contraceptives market report provides a global historical and forecasted market covering drug outreach globally.

  3. The Contraceptives market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Contraceptives market.

To know more about Contraceptives Market Analysis, visit @ Contraceptives Market Report

Comments

Post a Comment

Popular posts from this blog

The Great PD-1 Inhibitor Battle: OPDIVO vs. KEYTRUDA in Japan

Image
  Analyzing OPDIVO’s Pre-2022 Sales Decline and KEYTRUDA’s Market Ascendancy Before 2022, OPDIVO, developed by Bristol-Myers Squibb (BMS), faced a significant sales decline in Japan’s PD-1 inhibitor market. Despite its initial success, the PD-1 and PD-L1 inhibitors faced challenges from new competitors and evolving market dynamics. One key competitor was Merck's KEYTRUDA, which steadily gained market share due to its broader range of approved indications and successful clinical trial outcomes. KEYTRUDA’s market ascendancy was marked by its approval for various cancers, including melanoma, non-small cell lung cancer, and urothelial carcinoma, among others, making it a versatile choice for oncologists. How OPDIVO Outpaced KEYTRUDA in Japan’s Pharmaceutical Market In 2022, OPDIVO made a remarkable comeback, outpacing KEYTRUDA in Japan’s pharmaceutical market. This resurgence was driven by several strategic moves by BMS. The company expanded OPDIVO’s indications, securing approvals fo
Read more

A detailed analysis of Vascular Stents Market Trends, Growth Opportunities, Challenges, and Epidemiology Forecast

Image
A vascular surgeon places a stent, which is a hollow mesh tube that supports the blood vessel's walls permanently and prevents it from closing up again (restenosis). Some stents are drug-eluting, which means they release medicine over time to help prevent another blockage. The  Vascular Stents market is being driven by a growing geriatric population as well as an increase in the number of surgical operations. The  Vascular Stents Market report from DelveInsight provides an in-depth analysis of  Vascular Stents, as well as historical and forecasted market trends in the 7MM (the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some Key Highlights from the  Vascular Stents Market Report The artery is kept open by a stent, which is a small metal mesh tube. The two methods for opening clogged peripheral arteries are angioplasty and stent implantation. Vascular Stents market is segmented on the basis of Product type, By Applications and End-user. Some of the
Read more
Image
Obstructive Sleep Apnea Market Trends and Therapeutic Advancements !! Obstructive Sleep Apnea (OSA) is a common chronic sleep disorder, which is characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to a complete or partial obstruction of the airway, results of which are apneas, hypopneas, or sometimes both. Obstructive sleep apnea is a chronic and permanent condition, through proper therapy and medications the condition can be cured. Almost every system in the body is affected by Obstructive Sleep Apnea, resulting in an increased incidence of hypertension, stroke, altered immune system, and cardiovascular disease.  Obstructive Sleep Apnea is caused when the throat muscles relax during sleep, which causes the tissue in the back of the throat to collapse and block the upper airway. Daytime sleepiness is one of the most common symptoms of Obstructive Sleep Apnea. People affected with Obstructive Apnea also complain of memory problems, headach
Read more